Cargando…
Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
BACKGROUND: Hyaluronan accumulation correlates with the degree of malignancy in many solid tumor types, including malignant endometrial carcinomas. To elucidate the mechanism of hyaluronan accumulation, we examined the expression levels of the hyaluronan synthases (HAS1, HAS2 and HAS3) and hyaluroni...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956733/ https://www.ncbi.nlm.nih.gov/pubmed/20875124 http://dx.doi.org/10.1186/1471-2407-10-512 |
_version_ | 1782188185793593344 |
---|---|
author | Nykopp, Timo K Rilla, Kirsi Tammi, Markku I Tammi, Raija H Sironen, Reijo Hämäläinen, Kirsi Kosma, Veli-Matti Heinonen, Seppo Anttila, Maarit |
author_facet | Nykopp, Timo K Rilla, Kirsi Tammi, Markku I Tammi, Raija H Sironen, Reijo Hämäläinen, Kirsi Kosma, Veli-Matti Heinonen, Seppo Anttila, Maarit |
author_sort | Nykopp, Timo K |
collection | PubMed |
description | BACKGROUND: Hyaluronan accumulation correlates with the degree of malignancy in many solid tumor types, including malignant endometrial carcinomas. To elucidate the mechanism of hyaluronan accumulation, we examined the expression levels of the hyaluronan synthases (HAS1, HAS2 and HAS3) and hyaluronidases (HYAL1 and HYAL2), and correlated them with hyaluronan content and HAS1-3 immunoreactivity. METHODS: A total of 35 endometrial tissue biopsies from 35 patients, including proliferative and secretory endometrium (n = 10), post-menopausal proliferative endometrium (n = 5), complex atypical hyperplasia (n = 4), grade 1 (n = 8) and grade 2 + 3 (n = 8) endometrioid adenocarcinomas were divided for gene expression by real-time RT-PCR, and paraffin embedded blocks for hyaluronan and HAS1-3 cytochemistry. RESULTS: The mRNA levels of HAS1-3 were not consistently changed, while the immunoreactivity of all HAS proteins was increased in the cancer epithelium. Interestingly, HAS3 mRNA, but not HAS3 immunoreactivity, was increased in post-menopausal endometrium compared to normal endometrium (p = 0.003). The median of HYAL1 mRNA was 10-fold and 15-fold lower in both grade 1 and grade 2+3 endometrioid endometrial cancers, as compared to normal endometrium (p = 0.004-0.006), and post-menopausal endometrium (p = 0.002), respectively. HYAL2 mRNA was also reduced in cancer (p = 0.02) and correlated with HYAL1 (r = 0.8, p = 0.0001). There was an inverse correlation between HYAL1 mRNA and the epithelial hyaluronan staining intensity (r = -0.6; P = 0.001). CONCLUSION: The results indicated that HYAL1 and HYAL2 were coexpressed and significantly downregulated in endometrioid endometrial cancer and correlated with the accumulation of hyaluronan. While immunoreactivity for HASs increased in the cancer cells, tumor mRNA levels for HASs were not changed, suggesting that reduced turnover of HAS protein may also have contributed to the accumulation of hyaluronan. |
format | Text |
id | pubmed-2956733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29567332010-10-19 Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma Nykopp, Timo K Rilla, Kirsi Tammi, Markku I Tammi, Raija H Sironen, Reijo Hämäläinen, Kirsi Kosma, Veli-Matti Heinonen, Seppo Anttila, Maarit BMC Cancer Research Article BACKGROUND: Hyaluronan accumulation correlates with the degree of malignancy in many solid tumor types, including malignant endometrial carcinomas. To elucidate the mechanism of hyaluronan accumulation, we examined the expression levels of the hyaluronan synthases (HAS1, HAS2 and HAS3) and hyaluronidases (HYAL1 and HYAL2), and correlated them with hyaluronan content and HAS1-3 immunoreactivity. METHODS: A total of 35 endometrial tissue biopsies from 35 patients, including proliferative and secretory endometrium (n = 10), post-menopausal proliferative endometrium (n = 5), complex atypical hyperplasia (n = 4), grade 1 (n = 8) and grade 2 + 3 (n = 8) endometrioid adenocarcinomas were divided for gene expression by real-time RT-PCR, and paraffin embedded blocks for hyaluronan and HAS1-3 cytochemistry. RESULTS: The mRNA levels of HAS1-3 were not consistently changed, while the immunoreactivity of all HAS proteins was increased in the cancer epithelium. Interestingly, HAS3 mRNA, but not HAS3 immunoreactivity, was increased in post-menopausal endometrium compared to normal endometrium (p = 0.003). The median of HYAL1 mRNA was 10-fold and 15-fold lower in both grade 1 and grade 2+3 endometrioid endometrial cancers, as compared to normal endometrium (p = 0.004-0.006), and post-menopausal endometrium (p = 0.002), respectively. HYAL2 mRNA was also reduced in cancer (p = 0.02) and correlated with HYAL1 (r = 0.8, p = 0.0001). There was an inverse correlation between HYAL1 mRNA and the epithelial hyaluronan staining intensity (r = -0.6; P = 0.001). CONCLUSION: The results indicated that HYAL1 and HYAL2 were coexpressed and significantly downregulated in endometrioid endometrial cancer and correlated with the accumulation of hyaluronan. While immunoreactivity for HASs increased in the cancer cells, tumor mRNA levels for HASs were not changed, suggesting that reduced turnover of HAS protein may also have contributed to the accumulation of hyaluronan. BioMed Central 2010-09-27 /pmc/articles/PMC2956733/ /pubmed/20875124 http://dx.doi.org/10.1186/1471-2407-10-512 Text en Copyright ©2010 Nykopp et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Nykopp, Timo K Rilla, Kirsi Tammi, Markku I Tammi, Raija H Sironen, Reijo Hämäläinen, Kirsi Kosma, Veli-Matti Heinonen, Seppo Anttila, Maarit Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma |
title | Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma |
title_full | Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma |
title_fullStr | Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma |
title_full_unstemmed | Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma |
title_short | Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma |
title_sort | hyaluronan synthases (has1-3) and hyaluronidases (hyal1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956733/ https://www.ncbi.nlm.nih.gov/pubmed/20875124 http://dx.doi.org/10.1186/1471-2407-10-512 |
work_keys_str_mv | AT nykopptimok hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma AT rillakirsi hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma AT tammimarkkui hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma AT tammiraijah hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma AT sironenreijo hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma AT hamalainenkirsi hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma AT kosmavelimatti hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma AT heinonenseppo hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma AT anttilamaarit hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma |